Beijing Minhai Biotechnology Co Ltd - Product Pipeline Review - 2016

  • ID: 4035461
  • Company Profile
  • 50 pages
  • Global Markets Direct
1 of 4
Beijing Minhai Biotechnology Co Ltd - Product Pipeline Review - 2016

Summary

‘Beijing Minhai Biotechnology Co Ltd - Product Pipeline Review - 2016’, provides an overview of the Beijing Minhai Biotechnology Co Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Beijing Minhai Biotechnology Co Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Beijing Minhai Biotechnology Co Ltd
- The report provides overview of Beijing Minhai Biotechnology Co Ltd including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Beijing Minhai Biotechnology Co Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Beijing Minhai Biotechnology Co Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Beijing Minhai Biotechnology Co Ltd’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Beijing Minhai Biotechnology Co Ltd
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Beijing Minhai Biotechnology Co Ltd’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Introduction

Beijing Minhai Biotechnology Co Ltd Snapshot

Beijing Minhai Biotechnology Co Ltd Overview

Key Facts

Beijing Minhai Biotechnology Co Ltd - Research and Development Overview

Key Therapeutic Areas

Beijing Minhai Biotechnology Co Ltd - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Beijing Minhai Biotechnology Co Ltd - Pipeline Products Glance

Beijing Minhai Biotechnology Co Ltd - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Beijing Minhai Biotechnology Co Ltd - Clinical Stage Pipeline Products

Phase I Products/Combination Treatment Modalities

Beijing Minhai Biotechnology Co Ltd - Early Stage Pipeline Products

IND/CTA Filed Products/Combination Treatment Modalities

Preclinical Products/Combination Treatment Modalities

Beijing Minhai Biotechnology Co Ltd - Drug Profiles

(diphtheria + Haemophilus influenza [serotype B] + pertussis (acellular) + polio + tetanus) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(diphtheria + pertussis (acellular) + tetanus) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(hepatitis A + hepatitis B) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(measles + rubella + varicella) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

cholera (trivalent) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Enterovirus [serotype EV-A71] vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Haemophilus influenzae B vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

hepatitis A vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

hepatitis B vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

herpes simplex virus vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

herpes zoster vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

human papillomavirus (quadrivalent) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

influenza (split virion) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

influenza [strain A/H1N1] vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

influenza [strain A/H7N9] vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

meningococcal [serotype B] vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

meningococcal [serotypes A, C, W-135, Y] (tetravalent) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

meningococcal [serotypes A, C, W-135, Y] (tetravalent) vaccine 2 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

mumps vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

pneumococcal (13-valent) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

pneumococcal (23-valent) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

rabies vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

rotavirus (pentavalent) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

varicella zoster vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Beijing Minhai Biotechnology Co Ltd - Pipeline Analysis

Beijing Minhai Biotechnology Co Ltd - Pipeline Products by Route of Administration

Beijing Minhai Biotechnology Co Ltd - Pipeline Products by Molecule Type

Beijing Minhai Biotechnology Co Ltd - Dormant Projects

Beijing Minhai Biotechnology Co Ltd - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables:

Beijing Minhai Biotechnology Co Ltd, Key Facts

Beijing Minhai Biotechnology Co Ltd - Pipeline by Indication, 2016

Beijing Minhai Biotechnology Co Ltd - Pipeline by Stage of Development, 2016

Beijing Minhai Biotechnology Co Ltd - Monotherapy Products in Pipeline, 2016

Beijing Minhai Biotechnology Co Ltd - Combination Treatment Modalities in Pipeline, 2016

Beijing Minhai Biotechnology Co Ltd - Partnered Products in Pipeline, 2016

Beijing Minhai Biotechnology Co Ltd - Partnered Products/ Combination Treatment Modalities, 2016

Beijing Minhai Biotechnology Co Ltd - Pre-Registration, 2016

Beijing Minhai Biotechnology Co Ltd - Phase III, 2016

Beijing Minhai Biotechnology Co Ltd - Phase I, 2016

Beijing Minhai Biotechnology Co Ltd - IND/CTA Filed, 2016

Beijing Minhai Biotechnology Co Ltd - Preclinical, 2016

Beijing Minhai Biotechnology Co Ltd - Pipeline by Route of Administration, 2016

Beijing Minhai Biotechnology Co Ltd - Pipeline by Molecule Type, 2016

Beijing Minhai Biotechnology Co Ltd - Dormant Developmental Projects,2016

List of Figures:

Beijing Minhai Biotechnology Co Ltd - Pipeline by Top 10 Indication, 2016

Beijing Minhai Biotechnology Co Ltd - Pipeline by Stage of Development, 2016

Beijing Minhai Biotechnology Co Ltd - Monotherapy Products in Pipeline, 2016

Beijing Minhai Biotechnology Co Ltd - Combination Treatment Modalities in Pipeline, 2016

Beijing Minhai Biotechnology Co Ltd - Pipeline by Route of Administration, 2016

Beijing Minhai Biotechnology Co Ltd - Pipeline by Molecule Type,
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll